Document is current
Any future updates will be listed below
-
Authors
Furuhata, Yuichi
Rix, Gordon
Van Deventer, James A. https://orcid.org/0000-0003-4343-6157
Liu, Chang C. https://orcid.org/0000-0002-3290-2880
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM136297)
- License Information
-
More Information
Article History
Received: 7 October 2024
Accepted: 13 May 2025
First Online: 24 May 2025
Competing interests
: C.C.L. is a co-founder of K2 Therapeutics, which uses OrthoRep for protein engineering. The remaining authors declare no competing interests.
